Showing posts with label Seminar. Show all posts
Showing posts with label Seminar. Show all posts

30 Jul 2021

2 Aug talk by Prof Merlin Thomas, "More than the messenger: The disruptive technology of RNA therapeutics"

More than the messenger: The disruptive technology of RNA therapeutics

RNA therapeutics are a disruptive technology with the potential to actualize personalized medicine. Most RNA does not encode sequences for protein synthesis (mRNA; e.g. for vaccines). These other functions can be harnessed to selectively modulate protein expression by silencing, binding as aptamers and altering mRNA splicing. As an example, we are developing an oligonucleotide that modulates the alternate splicing of the Receptor for Advanced Glycation End-products (RAGE), a key therapeutic target in Alzheimer’s disease.


23 Nov 2020

Research update: Pregnancy as a Multiple Sclerosis disease modifier

See Dr Vilija Jokubaitis's research seminar highlights video
Dr Vilija Jokubaitis is a Senior Research Fellow in the Department of Neuroscience, Central Clinical School at Monash University. She is a clinical and translational neuroscientist with a particular interest in pregnancy and Multiple Sclerosis (MS). She published research in September on MS and pregnancy, then gave a seminar, in which she explored how pregnancy affects the progression of MS.The Zoom recording of the seminar has been edited and posted to the CCSMonash Youtube channel.

27 Jul 2018

What's on at CCS 30 July-03 August 2018

The AMREP Honours information evening is being held on
Thursday 2 Aug, starting at 6.00 pm. RSVP here. 
Central Clinical School (CCS) has regular seminar series and postgraduate presentations. Event notices are posted on the CCS Events calendar.

CCS staff and students can see details of both public and local events (including professional development courses, trade fairs and Graduate Research Student calendars) and deadlines, at the CCS intranet's Announcements page.

See CCS seminar index:  www.monash.edu/medicine/ccs/headlines/events-calendar

What's on at CCS 30 July-03 August 2018

15 Sept 2017

Neural control of artificial limbs via osseointegrated implants: Dr. Max Ortiz Catalán

Dr Max Ortiz Catalán giving a TED talk on osseointegration. Link
You are invited to attend a Central Clinical School seminar at the AMREP seminar room on Bionic Limbs Integrated to Bone, Nerves, and Muscles.


Dr Max Ortiz Catalán will shed light on how biology and mechatronics can integrate man and machine through intuitive prosthetics, controlled by the mind.

The Alfred’s Mr Frank Bruscino-Raiola Director of Plastic Surgery, Mr Steven Gray, and the Alfred Hospital Osseointegration and Targeted Muscle Reinnervation Team, have helped to pioneer this revolutionary technique which enables amputees to gain better and more natural control of their prosthetic arm. They have strong collaborations with leading centres around the world, including Integrum in Sweden and Rehabilitation Institute in Chicago.

This event is co-hosted by the Plastic Surgery Unit at the Alfred Hospital and the Department of Surgery, Central Clinical School, Monash University, Alfred Centre.

Details:

Dr Ortiz Catalán's research focuses on neural control of artificial limbs via osseointegrated implants. This involves bio-electric signals acquisition and processing, neural interfaces, machine learning, osseointegration, and neurostimulation. He is also interested in the use of virtual and augmented reality for neuromuscular rehabilitation and treatment of phantom limb pain (PLP) using myoelectric pattern recognition to decode motor volition.

Dr Ortiz Catalán is leading the development and clinical implementation of the Osseointegrated Human-Machine Gateway. This technology made possible, for the first time, the direct connection of a robotic prosthesis to the patients' bone, nerves, and muscles. He has also developed a novel treatment for phantom limb pain, which is currently under an international clinical investigation. These projects have in common the use of bioelectric pattern recognition (BioPatRec) for the decoding of motor intention. Dr. Ortiz Catalan has made the algorithms necessary for such task available in an open source platform for research and development (BioPatRec). He founded and leads the Biomechatronics and Neurorehabilitation Laboratory​​, and he is an Associate Editor for the Journal of NeuroEngineering and Rehabilitation (JNER).

Dr Max Ortiz Catalán is an Assistant Professor at the Biomedical Signals and Systems research unit, and founder of the Biomechatronics and Neurorehabilitation Laboratory (@ChalmersBNL). He works in close collaboration with the Centre for Advanced Reconstruction of Extremities (C.A.R.E.) at Sahlgrenska University Hospital, and Integrum AB, both in Gothenburg, Sweden.

10 Jun 2016

Immunology 'Cutting Edge' seminar series: Gut microbiota drive autoimmune arthritis

Dr Evelyn Tsantikos, Research Officer
in A/Prof Margaret Hibbs' group
Dr Evelyn Tsantikos will present the Immunity paper: "Gut Microbiota Drive Autoimmune Arthritis by Promoting Differentiation and Migration of Peyer’s Patch T Follicular Helper Cells". Reference: http://www.ncbi.nlm.nih.gov/pubmed/27096318

Recent studies have shown that alterations in gut microbiota (dysbiosis) can lead to many autoimmune diseases, including diseases with clear association to the gut, notably inflammatory bowel disease. However, the cellular and molecular mechanisms by which microbiota in the gut influence systemic autoimmune diseases such as rheumatoid arthritis (RA) remain largely unknown.

18 Feb 2016

22 Feb: Collaboration, Translation & Commercialisation​: Finding a Path to Success​

BioMedVic is holding a special event on Monday 22 Feb – Collaboration, Translation & Commercialisation​: Finding a Path to Success​

Dr Warwick Tong (pictured) will outline how the CTx CRC approaches research translation & commericalisation and the pathway that led to its recently announced multimillion dollar licensing deal.




1 May 2015

7 May Seminar: The tetraspanin CD82 and autophagy - its role in host defense

This Special Seminar will be held 12‐1pm on Thursday 7 May 2015 in the AMREP Education Centre Lecture theatre. All welcome.

A/Prof Jatin Vyas from the Harvard Medical School, USA will speak on "The tetraspanin CD82 and autophagy - its role in host defense". Prof Vyas’ laboratory has expertise in the interactions between dendritic cells and fungal pathogens, focusing on the role of Dectin-1, LC-3 (member of the autophagy family of proteins), Toll-like receptors and tetraspanins and their effects on phagosomal maturation. Please join us after the seminar for light refreshments.

See more about the Department of Immunology seminars: www.med.monash.edu.au/immunology/teaching/seminars.html
Related Posts Plugin for WordPress, Blogger...